Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Glioblastoma 12Gliosarcoma 9Central Nervous System Neoplasms 6Astrocytoma 6Brain Neoplasms 5Oligodendroglioma 4Glioma 4Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 2Ovarian Neoplasms 2Glioma, Subependymal 2Ependymoma 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sinonasal Squamous Cell Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Pinealoma 1Pheochromocytoma 1Peritoneal Neoplasms 1Pancreatic Intraductal Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Mesothelioma 1Meningioma 1Melanoma 1

Interventions

Tamoxifen 6Specimen Handling 4Neoadjuvant Therapy 3Radiotherapy 2Chemotherapy, Adjuvant 2Biopsy 2Anastrozole 2trastuzumab biosimilar HLX02 1sargramostim 1exemestane 1UAB 30 1Trastuzumab 1Surgical Procedures, Operative 1Sulindac 1Polymerase Chain Reaction 1PF-05280014 1Ontruzant 1Omacor 1Ogivri 1Magnetic Resonance Spectroscopy 1Letrozole 1Lapatinib 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Immunoenzyme Techniques 1High-Energy Shock Waves 1HER2 peptide (369-377) 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fulvestrant 1Docosahexaenoic Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Carcinoma, Intraductal, Noninfiltrating × Surgical Procedures, Operative × Clear all
NCT02636582 2023-12-05

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
43 enrolled 10 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡